1. Home
  2. COFS vs GNFT Comparison

COFS vs GNFT Comparison

Compare COFS & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COFS
  • GNFT
  • Stock Information
  • Founded
  • COFS 1898
  • GNFT 1999
  • Country
  • COFS United States
  • GNFT France
  • Employees
  • COFS N/A
  • GNFT N/A
  • Industry
  • COFS Major Banks
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • COFS Finance
  • GNFT Health Care
  • Exchange
  • COFS Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • COFS 322.9M
  • GNFT 296.4M
  • IPO Year
  • COFS N/A
  • GNFT 2019
  • Fundamental
  • Price
  • COFS $35.54
  • GNFT $4.50
  • Analyst Decision
  • COFS Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • COFS 1
  • GNFT 1
  • Target Price
  • COFS $37.00
  • GNFT $13.00
  • AVG Volume (30 Days)
  • COFS 36.2K
  • GNFT 6.3K
  • Earning Date
  • COFS 10-23-2024
  • GNFT 09-19-2024
  • Dividend Yield
  • COFS 3.04%
  • GNFT N/A
  • EPS Growth
  • COFS 5.14
  • GNFT N/A
  • EPS
  • COFS 3.16
  • GNFT 0.47
  • Revenue
  • COFS $87,896,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • COFS N/A
  • GNFT $155.44
  • Revenue Next Year
  • COFS $77.96
  • GNFT N/A
  • P/E Ratio
  • COFS $11.23
  • GNFT $9.31
  • Revenue Growth
  • COFS 8.01
  • GNFT 175.45
  • 52 Week Low
  • COFS $21.52
  • GNFT $3.08
  • 52 Week High
  • COFS $37.00
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • COFS 67.97
  • GNFT 28.81
  • Support Level
  • COFS $34.73
  • GNFT $5.10
  • Resistance Level
  • COFS $36.44
  • GNFT $5.81
  • Average True Range (ATR)
  • COFS 0.84
  • GNFT 0.21
  • MACD
  • COFS 0.12
  • GNFT -0.16
  • Stochastic Oscillator
  • COFS 68.60
  • GNFT 6.13

About COFS ChoiceOne Financial Services Inc.

ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: